Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation
✍ Scribed by Gayther, Simon A.; Warren, William; Mazoyer, Sylvie; Russell, Paul A.; Harrington, Patricia A.; Chiano, Mathias; Seal, Sheila; Hamoudi, Rifat; van Rensburg, Elizabeth J.; Dunning, Alison M.
- Book ID
- 109918889
- Publisher
- Nature Publishing Group
- Year
- 1995
- Tongue
- English
- Weight
- 739 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1061-4036
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The two major hereditary breast/ovarian cancer predisposition tumor suppressor genes, BRCA1 and BRCA2 that perform apparently generic cellular functions nonetheless cause tissue-specific syndromes in the human population when they are altered, or mutated in the germline. However, little is known abo
## Abstract BARD1 (BRCA1‐associated RING domain) was identified by yeast two‐hybrid screening as a protein interacting with BRCA1. Somatic and germline mutations of __BARD1__ have been detected in sporadic breast, ovarian, and endometrial cancers. The present study represents the first description
Women harboring BRCA1 germline mutations carry an 85% lifetime risk of developing breast cancer and a 63% risk of ovarian cancer. In this first systematic study of familial breast and/or ovarian cancer in Germany we investigated 29 families for germline mutations in the BRCA1 gene. We identified mut
BRCA1 is a tumour suppressor gene located on chromosome band 17q21. It is estimated that mutations in the BRCA1 gene account for approximately 45% of the breast cancer families and almost all of the breast/ovarian cancer families. We have used single strand conformation polymorphism analysis, direct